Compare ABUS & THRM Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | ABUS | THRM |
|---|---|---|
| Founded | 2005 | 1991 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Biotechnology: Pharmaceutical Preparations | Auto Parts:O.E.M. |
| Sector | Health Care | Consumer Discretionary |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 815.5M | 844.7M |
| IPO Year | 2008 | 1996 |
| Metric | ABUS | THRM |
|---|---|---|
| Price | $4.51 | $27.66 |
| Analyst Decision | Strong Buy | Buy |
| Analyst Count | 1 | 5 |
| Target Price | $5.00 | ★ $39.40 |
| AVG Volume (30 Days) | ★ 2.1M | 190.3K |
| Earning Date | 05-13-2026 | 04-23-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | ★ 55.26 | N/A |
| EPS | N/A | ★ 0.59 |
| Revenue | $14,083,000.00 | ★ $554,979,000.00 |
| Revenue This Year | N/A | $5.43 |
| Revenue Next Year | $783.24 | $7.47 |
| P/E Ratio | ★ N/A | $47.05 |
| Revenue Growth | ★ 128.21 | 50.16 |
| 52 Week Low | $2.71 | $22.75 |
| 52 Week High | $5.10 | $39.48 |
| Indicator | ABUS | THRM |
|---|---|---|
| Relative Strength Index (RSI) | 52.10 | 39.41 |
| Support Level | $4.19 | $27.00 |
| Resistance Level | $4.71 | $29.37 |
| Average True Range (ATR) | 0.20 | 0.89 |
| MACD | 0.01 | 0.14 |
| Stochastic Oscillator | 68.00 | 32.07 |
Arbutus Biopharma Corp is a clinical-stage biopharmaceutical company focused on infectious diseases. The company is leveraging its extensive virology expertise to identify and develop novel therapeutics with distinct mechanisms of action, which can be combined to provide a functional cure for patients with chronic hepatitis B virus (cHBV). Its pipeline of internally developed, proprietary compounds includes an RNAi therapeutic, imdusiran (AB-729), and an oral PD-L1 inhibitor, AB-101. In addition, the company is also focused on maximizing the opportunity for its in-house developed Lipid Nanoparticle (LNP) delivery technology.
Gentherm Inc is an automotive parts manufacturer. The business activities of the group function through the Automotive and Medical segments. The vast majority of the firm's revenue comes from the Automotive segment, which includes automotive climate comfort systems, automotive cable systems, battery performance solutions, and automotive electronics and software systems. The medical segment is comprised of the results from the patient temperature management business in the medical industry. Its geographical segments are the USA, China, South Korea, Germany, Japan, the Czech Republic, and other countries.